Deerfield Management Company, L.p. (series C) - Net Worth and Insider Trading
Deerfield Management Company, L.p. (series C) Net Worth
The estimated net worth of Deerfield Management Company, L.p. (series C) is at least $56 Million dollars as of 2024-11-05. Deerfield Management Company, L.p. (series C) is the of DA32 Life Science Tech Acquisition Corp and owns about 3,850,000 shares of DA32 Life Science Tech Acquisition Corp (DALS) stock worth over $40 Million. Deerfield Management Company, L.p. (series C) is also the of eHealth Inc and owns about 3,264,588 shares of eHealth Inc (EHTH) stock worth over $17 Million. Details can be seen in Deerfield Management Company, L.p. (series C)'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deerfield Management Company, L.p. (series C) has not made any transactions after 2021-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deerfield Management Company, L.p. (series C)
Deerfield Management Company, L.p. (series C) Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deerfield Management Company, L.p. (series C) owns 85 companies in total, including Oncorus Inc (ONCR) , Larimar Therapeutics Inc (LRMR) , and CalciMedica Inc (CALC) among others .
Insider Ownership Summary of Deerfield Management Company, L.p. (series C)
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCR | Oncorus Inc | 2020-10-01 | director & 10 percent owner & other: *Possible Member of 10% Group |
| LRMR | Larimar Therapeutics Inc | 2016-02-09 | 10 percent owner & other: Possible Member of 10% Group |
| CALC | CalciMedica Inc | 2020-09-24 | 10 percent owner & other: Possible Member of 10% Group |
 | | 2020-08-05 | director & 10 percent owner & other: Director by Deputization |
| | 2020-07-23 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-07-21 | director & 10 percent owner & other: Director by Deputization |
| | 2020-07-09 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-06-11 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-03-18 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-03-13 | director & 10 percent owner & other: Director by Deputization |
| | 2020-02-12 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-02-05 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-01-29 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-03-27 | 10 percent owner & other: *Director by Deputization |
| | 2019-11-08 | director & 10 percent owner & other: * Director by Deputization |
| | 2019-10-24 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-07-17 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-10-22 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-03-06 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-02-08 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-09-26 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-07-23 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-07-23 | 10 percent owner & other: Possible member of 10% group |
| | 2018-04-30 | 10 percent owner & other: *Possible member of 10% group |
| | 2014-10-21 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-05-23 | 10 percent owner & other: *Possible member of 10% group |
| | 2018-05-08 | 10 percent owner & other: *Possible member of 10% group |
| | 2018-02-15 | 10 percent owner & other: Possible Member of 10% Group |
| | 2017-10-04 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-12-16 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-03-06 | 10 percent owner & other: Possible Member of 10% Group |
| | 2017-01-24 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-12-12 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-12-23 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-06-16 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-07-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-02-10 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-06-29 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-02-19 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-02-10 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-02-02 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-07-10 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-05-11 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-09-16 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-07-28 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-05-06 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-03-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-02-11 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-11-21 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-08-06 | 10 percent owner & other: Possible Members of 10% Group |
| | 2014-08-05 | 10 percent owner & other: Possible Members of 10% Group |
| | 2014-04-22 | 10 percent owner & other: Possible Members of 10% Group |
| | 2012-12-04 | 10 percent owner & other: Possible Member of 10% Group |
| | 2010-11-03 | 10 percent owner & other: Possible Members of 10% Group |
| | 2011-04-04 | 10 percent owner & other: Possible Members of 10% Group |
| | 2008-10-27 | 10 percent owner |
| | 2010-08-16 | 10 percent owner & other: Possible Members of 10% Group |
| | 2009-07-13 | 10 percent owner |
| | 2008-03-11 | 10 percent owner |
| | 2006-01-31 | 10 percent owner & other: Possible Members of 10% Group |
| | 2007-11-05 | 10 percent owner & other: Possible Member of 10% Group |
| | 2007-10-19 | 10 percent owner |
| | 2021-03-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-02-15 | director & 10 percent owner & other: Director by Deputization |
| | 2021-04-29 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-03-10 | director & 10 percent owner & other: *Director by Deputization |
| | 2020-07-16 | director & 10 percent owner & other: *Director by Deputization |
| | 2020-02-04 | 10 percent owner & other: Possible Member of 10% Group |
| | 2020-02-01 | 10 percent owner & other: Possible Member of 10% Group |
| | 2022-05-05 | 10 percent owner & other: *Possible Member of 10% Group |
| | 2021-10-21 | 10 percent owner & other: *Possible Member of 10% Group |
| | 2021-05-26 | 10 percent owner & other: *Possible Member of 10% Group |
| | 2021-07-28 | director & 10 percent owner & other: Director by Deputization |
| | 2021-07-30 | director & 10 percent owner & other: Director by deputization |
| | 2020-02-01 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-05-08 | 10 percent owner & other: *Possible member of 10% group |
| | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
| | 2020-02-01 | 10 percent owner & other: Possible Member of 10% Group |
| | 2022-11-08 | 10 percent owner & other: Possible Member of 10% Group |
| | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
| | 2022-11-08 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-10-02 | 10 percent owner & other: Possible Member of 10% Group |
Deerfield Management Company, L.p. (series C) Latest Holdings Summary
Deerfield Management Company, L.p. (series C) currently owns a total of 2 stocks. Among these stocks, Deerfield Management Company, L.p. (series C) owns 3,850,000 shares of DA32 Life Science Tech Acquisition Corp (DALS) as of July 30, 2021, with a value of $40 Million and a weighting of 70.55%. Deerfield Management Company, L.p. (series C) also owns 3,264,588 shares of eHealth Inc (EHTH) as of March 6, 2015, with a value of $17 Million and a weighting of 29.45%.
Latest Holdings of Deerfield Management Company, L.p. (series C)
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DALS | DA32 Life Science Tech Acquisition Corp | 2021-07-30 | 3,850,000 | 10.32 | 39,732,000 |
| EHTH | eHealth Inc | 2015-03-06 | 3,264,588 | 5.08 | 16,584,107 |
Holding Weightings of Deerfield Management Company, L.p. (series C)
Deerfield Management Company, L.p. (series C) Form 4 Trading Tracker
According to the SEC Form 4 filings, Deerfield Management Company, L.p. (series C) has made a total of 1 transactions in DA32 Life Science Tech Acquisition Corp (DALS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DA32 Life Science Tech Acquisition Corp is the acquisition of 1,600,000 shares on July 30, 2021, which cost Deerfield Management Company, L.p. (series C) around $16 Million.
According to the SEC Form 4 filings, Deerfield Management Company, L.p. (series C) has made a total of 0 transactions in eHealth Inc (EHTH) over the past 5 years. The most-recent trade in eHealth Inc is the sale of 1,342,573 shares on March 6, 2015, which brought Deerfield Management Company, L.p. (series C) around $13 Million.
Insider Trading History of Deerfield Management Company, L.p. (series C)
- 1
Deerfield Management Company, L.p. (series C) Trading Performance
GuruFocus tracks the stock performance after each of Deerfield Management Company, L.p. (series C)'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deerfield Management Company, L.p. (series C) is -2%. GuruFocus also compares Deerfield Management Company, L.p. (series C)'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Deerfield Management Company, L.p. (series C) within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deerfield Management Company, L.p. (series C)'s insider trading performs compared to the benchmark.
Performance of Deerfield Management Company, L.p. (series C)
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.4 | | | | | |
| Relative Return to S&P 500(%) | -5.44 | | | | | |
Deerfield Management Company, L.p. (series C) Ownership Network
Ownership Network List of Deerfield Management Company, L.p. (series C)
Ownership Network Relation of Deerfield Management Company, L.p. (series C)
Deerfield Management Company, L.p. (series C) Owned Company Details
What does Oncorus Inc do?
Who are the key executives at Oncorus Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: *Possible Member of 10% Group of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .
Oncorus Inc (ONCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncorus Inc Insider Transactions
- Download to Excel(.xls)
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Gopi Shankar .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does CalciMedica Inc do?
Who are the key executives at CalciMedica Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , director & 10 percent owner & Chief Executive Officer A. Rachel Leheny , and 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp .
CalciMedica Inc (CALC) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 133,737 shares made by Eric W Roberts , a net purchase of 41,768 shares made by A. Rachel Leheny , and a net purchase of 167,560 shares made by Robert N Wilson .
In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 191,666 shares, with a net purchase of 191,666 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,761,802 shares were bought by its insiders, resulting in a net purchase of 1,761,802 shares.
CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CalciMedica Inc Insider Transactions
- Download to Excel(.xls)
What does Acutus Medical Inc do?
Who are the key executives at Acutus Medical Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .
Acutus Medical Inc (AFIB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acutus Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Annexon Inc do?
Who are the key executives at Annexon Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Innovation Officer Ted Yednock , EVP & Chief Financial Officer Jennifer Lew , and EVP & Chief Business Officer Michael Overdorf .
Annexon Inc (ANNX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .
In summary, during the past 3 months, insiders sold 26,408 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 20,008 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 672,400 shares were bought by its insiders, resulting in a net purchase of 580,008 shares.
Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Annexon Inc Insider Transactions
- Download to Excel(.xls)
What does Deerfield Healthcare Technology Acquisitions Corp do?
Who are the key executives at Deerfield Healthcare Technology Acquisitions Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of Deerfield Healthcare Technology Acquisitions Corp. Other key executives at Deerfield Healthcare Technology Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. , and director & 10 percent owner & other: Director by Deputization James E Flynn .
Deerfield Healthcare Technology Acquisitions Corp (DFHTU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Deerfield Healthcare Technology Acquisitions Corp (DFHTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deerfield Healthcare Technology Acquisitions Corp Insider Transactions
- Download to Excel(.xls)
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .
In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
- Download to Excel(.xls)
What does Generation Bio Co do?
Who are the key executives at Generation Bio Co?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Generation Bio Co. Other key executives at Generation Bio Co include CHIEF OPERATING OFFICER Antoinette Paone , CHIEF LEGAL OFFICER Yalonda Howze , and CHIEF STRATEGY OFFICER Phillip Samayoa .
Generation Bio Co (GBIO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net purchase of 20,000 shares made by Dannielle Appelhans , a net sale of 9,835 shares made by Antoinette Paone , and a net purchase of 342,960 shares made by Rowland Charles A Jr .
In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,835 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 541,620 shares.
Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Generation Bio Co Insider Transactions
- Download to Excel(.xls)
What does Lumos Pharma Inc do?
Who are the key executives at Lumos Pharma Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .
Lumos Pharma Inc (LUMO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lumos Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does DFP Healthcare Acquisitions Corp do?
Who are the key executives at DFP Healthcare Acquisitions Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of DFP Healthcare Acquisitions Corp. Other key executives at DFP Healthcare Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. , and director & 10 percent owner & other: Director by Deputization James E Flynn .
DFP Healthcare Acquisitions Corp (DFPHU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DFP Healthcare Acquisitions Corp (DFPHU)'s detailed insider trading history can be found in Insider Trading Tracker table.
DFP Healthcare Acquisitions Corp Insider Transactions
- Download to Excel(.xls)
What does Revolution Medicines Inc do?
Who are the key executives at Revolution Medicines Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include See Remarks Stephen Michael Kelsey , General Counsel Jeff Cislini , and See Remarks Margaret A Horn .
Revolution Medicines Inc (RVMD) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 186,391 shares made by Stephen Michael Kelsey , a net sale of 28,044 shares made by Jeff Cislini , and a net sale of 195,672 shares made by Mark A Goldsmith .
In summary, during the past 3 months, insiders sold 190,609 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 190,609 shares. During the past 18 months, 642,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 642,995 shares.
Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revolution Medicines Inc Insider Transactions
- Download to Excel(.xls)
What does Schrodinger Inc do?
Who are the key executives at Schrodinger Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Schrodinger Inc. Other key executives at Schrodinger Inc include Chief Medical Officer Margaret Dugan , EVP & CFO Geoffrey Craig Porges , and See Remarks Robert Lorne Abel .
Schrodinger Inc (SDGR) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Schrodinger Inc (SDGR). Other recent insider transactions involving Schrodinger Inc (SDGR) include a net sale of 35,758 shares made by Yvonne Tran , a net sale of 20,901 shares made by Kenneth Patrick Lorton , and a net sale of 14,850 shares made by Nancy Thornberry .
In summary, during the past 3 months, insiders sold 1,531 shares of Schrodinger Inc (SDGR) in total and bought 0 shares, with a net sale of 1,531 shares. During the past 18 months, 78,347 shares of Schrodinger Inc (SDGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,347 shares.
Schrodinger Inc (SDGR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Schrodinger Inc Insider Transactions
- Download to Excel(.xls)
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Director by Deputization of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
- Download to Excel(.xls)
What does AdaptHealth Corp do?
Who are the key executives at AdaptHealth Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: * Director by Deputization of AdaptHealth Corp. Other key executives at AdaptHealth Corp include Chief Accounting Officer Frank Mullen , 10 percent owner Oep Vii Project A-i Co-investment Partners, L.p. , and 10 percent owner Oep Vii Project A Co-investment Partners, L.p. .
AdaptHealth Corp (DFBHU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AdaptHealth Corp (DFBHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AdaptHealth Corp (DFBHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AdaptHealth Corp (DFBHU)'s detailed insider trading history can be found in Insider Trading Tracker table.
AdaptHealth Corp Insider Transactions
- Download to Excel(.xls)
What does Cabaletta Bio Inc do?
Who are the key executives at Cabaletta Bio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .
Cabaletta Bio Inc (CABA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,
In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.
Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabaletta Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Frequency Therapeutics Inc do?
Who are the key executives at Frequency Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .
Frequency Therapeutics Inc (FREQ) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .
In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.
Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frequency Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mirum Pharmaceuticals Inc do?
Who are the key executives at Mirum Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include director & 10 percent owner Patrick J Heron , SVP & Global Controller Jolanda Howe , and Chief Scientific Officer Pamela Vig .
Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net purchase of 162,308 shares made by Patrick J Heron , a net sale of 8,512 shares made by Jolanda Howe , and a net sale of 34,606 shares made by Pamela Vig .
In summary, during the past 3 months, insiders sold 0 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 345 shares, with a net purchase of 345 shares. During the past 18 months, 105,850 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 70,458 shares.
Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirum Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 14,705 shares made by James Loerop .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,878,247 shares were bought by its insiders, resulting in a net purchase of 4,860,247 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Shockwave Medical Inc do?
Who are the key executives at Shockwave Medical Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Shockwave Medical Inc. Other key executives at Shockwave Medical Inc include Chief Commercial Officer Isaac Zacharias , VP & Finance Trinh Phung , and director & President & CEO Douglas Evan Godshall .
Shockwave Medical Inc (SWAV) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Shockwave Medical Inc (SWAV). Other recent insider transactions involving Shockwave Medical Inc (SWAV) include a net sale of 44,000 shares made by Isaac Zacharias , a net sale of 27,000 shares made by Frank T Watkins , and a net sale of 70,000 shares made by Douglas Evan Godshall .
In summary, during the past 3 months, insiders sold 0 shares of Shockwave Medical Inc (SWAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 215,389 shares of Shockwave Medical Inc (SWAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 215,389 shares.
Shockwave Medical Inc (SWAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shockwave Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 8,800 shares, with a net purchase of 8,800 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Arvinas Inc. Other key executives at Arvinas Inc include Chief Medical Officer Ronald Peck , Chief Financial Officer Sean A Cassidy , and director & President and CEO John G Houston .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 3,023 shares made by Ronald Peck , a net sale of 5,196 shares made by John G Houston , and a net sale of 1,702 shares made by Sean A Cassidy .
In summary, during the past 3 months, insiders sold 0 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,622 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,622 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
- Download to Excel(.xls)
What does Aerie Pharmaceuticals Inc do?
Who are the key executives at Aerie Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .
Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerie Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Constellation Pharmaceuticals Inc do?
Who are the key executives at Constellation Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible member of 10% group of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .
Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Constellation Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 43,500 shares were bought by its insiders, resulting in a net sale of 60,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
- Download to Excel(.xls)
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 220,893 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 220,893 shares. During the past 18 months, 703,460 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 703,460 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Chief Business Officer Eben Tessari , Group VP & Rilonacept GM Ross Moat , and Chief Medical Officer John Paolini .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 219,460 shares made by Sanj K Patel , and a net sale of 52,000 shares made by Eben Tessari .
In summary, during the past 3 months, insiders sold 181,198 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 181,198 shares. During the past 18 months, 539,163 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 539,163 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
- Download to Excel(.xls)
What does Mallinckrodt PLC do?
Who are the key executives at Mallinckrodt PLC?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include director & President and CEO Sigurdur O Olafsson , EVP & Chief Sci. Ofcr Steven J. Romano , and 10 percent owner Fyi S.a R.l. .
Mallinckrodt PLC (MNKKQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mallinckrodt PLC Insider Transactions
- Download to Excel(.xls)
What does Catalyst Biosciences Inc do?
Who are the key executives at Catalyst Biosciences Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .
Catalyst Biosciences Inc (CBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 75,787 shares made by Pamela J. Cramer .
In summary, during the past 3 months, insiders sold 174,805 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 174,805 shares. During the past 18 months, 582,666 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 582,666 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Societal CDMO Inc do?
Who are the key executives at Societal CDMO Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Societal CDMO Inc. Other key executives at Societal CDMO Inc include director & Chief Executive Officer Enloe J David Jr , director & 10 percent owner Mathew Paul Arens , and 10 percent owner Awm Investment Company, Inc. .
Societal CDMO Inc (SCTL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Societal CDMO Inc (SCTL). Other recent insider transactions involving Societal CDMO Inc (SCTL) include a net purchase of 6,250,000 shares made by Mathew Paul Arens , a net purchase of 140,000 shares made by Awm Investment Company, Inc. , and a net purchase of 125,000 shares made by Enloe J David Jr .
In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc (SCTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Societal CDMO Inc (SCTL) were sold and 6,792,222 shares were bought by its insiders, resulting in a net purchase of 6,792,222 shares.
Societal CDMO Inc (SCTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Societal CDMO Inc Insider Transactions
- Download to Excel(.xls)
What does eHealth Inc do?
Who are the key executives at eHealth Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of eHealth Inc. Other key executives at eHealth Inc include SVP & General Counsel & Secr. Gavin G. Galimi , SVP & Chief Financial Officer John J Stelben , and director & Chief Executive Officer Soistman Francis S Jr .
eHealth Inc (EHTH) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in eHealth Inc (EHTH). Other recent insider transactions involving eHealth Inc (EHTH) include a net purchase of 24,865 shares made by Gavin G. Galimi , a net purchase of 27,932 shares made by Dale B Wolf , and a net purchase of 50,000 shares made by Soistman Francis S Jr .
In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc (EHTH) in total and bought 87,365 shares, with a net purchase of 87,365 shares. During the past 18 months, 0 shares of eHealth Inc (EHTH) were sold and 122,797 shares were bought by its insiders, resulting in a net purchase of 122,797 shares.
eHealth Inc (EHTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
eHealth Inc Insider Transactions
- Download to Excel(.xls)
What does CAS Medical Systems Inc do?
Who are the key executives at CAS Medical Systems Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of CAS Medical Systems Inc. Other key executives at CAS Medical Systems Inc include director & President and CEO Thomas M Patton , director & 10 percent owner James E Thomas , and 10 percent owner Thomas, Mcnerney & Partners Ii L.p. .
CAS Medical Systems Inc (CASM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CAS Medical Systems Inc (CASM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CAS Medical Systems Inc (CASM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CAS Medical Systems Inc (CASM)'s detailed insider trading history can be found in Insider Trading Tracker table.
CAS Medical Systems Inc Insider Transactions
- Download to Excel(.xls)
What does Invuity Inc do?
Who are the key executives at Invuity Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Invuity Inc. Other key executives at Invuity Inc include Chief Financial Officer James H Mackaness , 10 percent owner & other: Possible Member of 10% Group James E Flynn , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
Invuity Inc (IVTY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invuity Inc Insider Transactions
- Download to Excel(.xls)
What does Vanda Pharmaceuticals Inc do?
Who are the key executives at Vanda Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include VP & Acting CFO & Treasurer Kevin Patrick Moran , director & Chief Executive Officer Mihael Hristos Polymeropoulos , and SVP & General Counsel Timothy Williams .
Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 35,163 shares made by Kevin Patrick Moran , a net sale of 31,688 shares made by Timothy Williams , and a net sale of 20,451 shares made by Joakim Wijkstrom .
In summary, during the past 3 months, insiders sold 0 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 166,385 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 166,385 shares.
Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vanda Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Audentes Therapeutics Inc do?
Who are the key executives at Audentes Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Audentes Therapeutics Inc. Other key executives at Audentes Therapeutics Inc include President and COO Natalie C. Holles , SVP & Chief Medical Officer Edward R. Conner , and Executive Vice President & CFO Thomas P Soloway .
Audentes Therapeutics Inc (BOLD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Audentes Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Axogen Inc do?
Who are the key executives at Axogen Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Axogen Inc. Other key executives at Axogen Inc include Chief R&D Officer Angelo Scopelianos , director & CEO Karen L. Zaderej , and VP & Clinical&Translational Sc Erick Wayne Devinney .
Axogen Inc (AXGN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Axogen Inc (AXGN). Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 74,448 shares made by Gregory Gene Freitag , a net sale of 42,343 shares made by Michael Patrick Donovan , and a net sale of 39,280 shares made by Karen L. Zaderej .
In summary, during the past 3 months, insiders sold 0 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 180,030 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 150,030 shares.
Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axogen Inc Insider Transactions
- Download to Excel(.xls)
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Jason Haas .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XenoPort Inc do?
Who are the key executives at XenoPort Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. , and 10 percent owner & other: Possible Member of 10% Group Deerfield Partners, L.p. .
XenoPort Inc (XNPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
XenoPort Inc Insider Transactions
- Download to Excel(.xls)
What does AveXis Inc do?
Who are the key executives at AveXis Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of AveXis Inc. Other key executives at AveXis Inc include director & President & CEO Sean P. Nolan , 10 percent owner Ag Novartis , and Chief Financial Officer Phillip B. Donenberg .
AveXis Inc (AVXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
AveXis Inc Insider Transactions
- Download to Excel(.xls)
What does Editas Medicine Inc do?
Who are the key executives at Editas Medicine Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Editas Medicine Inc. Other key executives at Editas Medicine Inc include SVP & CHIEF MEDICAL OFFICER Baisong Mei , director & CEO Gilmore Neil O'neill , and EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly .
Editas Medicine Inc (EDIT) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 2,791 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .
In summary, during the past 3 months, insiders sold 2,073 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 2,073 shares. During the past 18 months, 168,311 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 123,311 shares.
Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Editas Medicine Inc Insider Transactions
- Download to Excel(.xls)
What does Streamline Health Solutions Inc do?
Who are the key executives at Streamline Health Solutions Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Streamline Health Solutions Inc. Other key executives at Streamline Health Solutions Inc include President Benjamin Louis Stilwill , Interim CFO Reeves Bryant J Iii , and Chief People Officer Wendy L Lucio .
Streamline Health Solutions Inc (STRM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Streamline Health Solutions Inc (STRM). Other recent insider transactions involving Streamline Health Solutions Inc (STRM) include a net purchase of 6,300 shares made by Benjamin Louis Stilwill ,
In summary, during the past 3 months, insiders sold 0 shares of Streamline Health Solutions Inc (STRM) in total and bought 420 shares, with a net purchase of 420 shares. During the past 18 months, 0 shares of Streamline Health Solutions Inc (STRM) were sold and 420 shares were bought by its insiders, resulting in a net purchase of 420 shares.
Streamline Health Solutions Inc (STRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Streamline Health Solutions Inc Insider Transactions
- Download to Excel(.xls)
What does Alimera Sciences Inc do?
Who are the key executives at Alimera Sciences Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .
Alimera Sciences Inc (ALIM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , and a net purchase of 1,401,901 shares made by Adam Morgan .
In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,401,901 shares.
Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alimera Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and See Remarks Peter J Graham .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .
In summary, during the past 3 months, insiders sold 20,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
- Download to Excel(.xls)
What does Neos Therapeutics Inc do?
Who are the key executives at Neos Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , Chief Financial Officer Richard I Eisenstadt , and SVP & General Counsel John M Limongelli .
Neos Therapeutics Inc (NEOS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .
aTyr Pharma Inc (ATYR) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 300,000 shares made by Paul Schimmel , and a net purchase of 3,410 shares made by Jill Marie Broadfoot .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 425,000 shares were bought by its insiders, resulting in a net purchase of 423,410 shares.
aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does SteadyMed Ltd do?
Who are the key executives at SteadyMed Ltd?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of SteadyMed Ltd. Other key executives at SteadyMed Ltd include 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp Vi Llc , and director & 10 percent owner Brian Jay Stark .
SteadyMed Ltd (STDY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.
SteadyMed Ltd Insider Transactions
- Download to Excel(.xls)
What does Invitae Corp do?
Who are the key executives at Invitae Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Invitae Corp. Other key executives at Invitae Corp include Chief Financial Officer Ana J. Schrank , Chief Commercial Officer Robert M. Guigley , and See Remarks Robert Iv Dickey .
Invitae Corp (NVTAQ) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 90,864 shares made by Kenneth D. Knight , a net sale of 86,904 shares made by Yafei Wen , and a net sale of 33,562 shares made by Robert L Nussbaum .
In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 266,444 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 266,444 shares.
Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invitae Corp Insider Transactions
- Download to Excel(.xls)
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Loxo Oncology Inc do?
Who are the key executives at Loxo Oncology Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .
Loxo Oncology Inc (LOXO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Loxo Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 302,064 shares made by Braden Michael Leonard , a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , and a net purchase of 100,000 shares made by Linda M Rubinstein .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 620 shares of Adverum Biotechnologies Inc (ADVM) were sold and 335,064 shares were bought by its insiders, resulting in a net purchase of 334,444 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
- Download to Excel(.xls)
What does TriVascular Technologies Inc do?
Who are the key executives at TriVascular Technologies Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .
TriVascular Technologies Inc (TRIV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
TriVascular Technologies Inc Insider Transactions
- Download to Excel(.xls)
What does NxStage Medical Inc do?
Who are the key executives at NxStage Medical Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of NxStage Medical Inc. Other key executives at NxStage Medical Inc include director & Chief Executive Officer Jeffrey H Burbank , Chief Accounting Officer Kevin Hershberger , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
NxStage Medical Inc (NXTM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc (NXTM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc (NXTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NxStage Medical Inc (NXTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NxStage Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .
In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does The Medicines Co do?
Who are the key executives at The Medicines Co?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of The Medicines Co. Other key executives at The Medicines Co include Chief Development Officer Peter Wijngaard , EVP & Chief Corp. Dev. Officer Christopher T Cox , and director & Executive Chairman Fredric N Eshelman .
The Medicines Co (MDCO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of The Medicines Co (MDCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of The Medicines Co (MDCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
The Medicines Co (MDCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
The Medicines Co Insider Transactions
- Download to Excel(.xls)
What does NeuroMetrix Inc do?
Who are the key executives at NeuroMetrix Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of NeuroMetrix Inc. Other key executives at NeuroMetrix Inc include Chief Financial Officer Thomas T Higgins , other: See Explanation in Footnotes Topline Capital Management, Llc , and 10 percent owner Topline Capital Partners, Lp .
NeuroMetrix Inc (NURO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in NeuroMetrix Inc (NURO). Other recent insider transactions involving NeuroMetrix Inc (NURO) include a net sale of 1,000 shares made by Joshua Horowitz ,
In summary, during the past 3 months, insiders sold 0 shares of NeuroMetrix Inc (NURO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000 shares of NeuroMetrix Inc (NURO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,000 shares.
NeuroMetrix Inc (NURO)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuroMetrix Inc Insider Transactions
- Download to Excel(.xls)
What does Fibrocell Science Inc do?
Who are the key executives at Fibrocell Science Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Fibrocell Science Inc. Other key executives at Fibrocell Science Inc include 10 percent owner Randal J Kirk , 10 percent owner Intrexon Corp , and director & Chairman and CEO David Pernock .
Fibrocell Science Inc (FCSC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Fibrocell Science Inc (FCSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fibrocell Science Inc (FCSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Fibrocell Science Inc (FCSC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fibrocell Science Inc Insider Transactions
- Download to Excel(.xls)
What does NeurogesX Inc do?
Who are the key executives at NeurogesX Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of NeurogesX Inc. Other key executives at NeurogesX Inc include President and CEO Ron Martell , Exec. V.P. & COO & CFO Stephen F Ghiglieri , and director & 10 percent owner Robert Nelsen .
NeurogesX Inc (NGSX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeurogesX Inc Insider Transactions
- Download to Excel(.xls)
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Dynavax Technologies Corp do?
Who are the key executives at Dynavax Technologies Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Members of 10% Group of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .
Dynavax Technologies Corp (DVAX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 169,000 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 3,000,000 shares made by Hack Andrew A. F. .
In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,247,529 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,247,529 shares.
Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dynavax Technologies Corp Insider Transactions
- Download to Excel(.xls)
What does VIA Pharmaceuticals Inc do?
Who are the key executives at VIA Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of VIA Pharmaceuticals Inc. Other key executives at VIA Pharmaceuticals Inc include 10 percent owner Bay City Capital Llc , 10 percent owner Bay City Capital Fund Iv Co Invesment Fund Lp , and 10 percent owner Bay City Capital Management Iv Llc .
VIA Pharmaceuticals Inc (VIAP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of VIA Pharmaceuticals Inc (VIAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIA Pharmaceuticals Inc (VIAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
VIA Pharmaceuticals Inc (VIAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
VIA Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Arena Pharmaceuticals Inc do?
Who are the key executives at Arena Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , EVP & Chief Commercial Officer Robert Lisicki , and Executive VP and CBO Vincent Aurentz .
Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arena Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Edgewise Therapeutics Inc do?
Who are the key executives at Edgewise Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Edgewise Therapeutics Inc. Other key executives at Edgewise Therapeutics Inc include General Counsel John R Moore , CMO Joanne M. Donovan , and Chief Financial Officer R Michael Carruthers .
Edgewise Therapeutics Inc (EWTX) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Edgewise Therapeutics Inc (EWTX). Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 111,210 shares made by John R Moore , a net sale of 249,161 shares made by Alan J Russell , and a net sale of 217,249 shares made by R Michael Carruthers .
In summary, during the past 3 months, insiders sold 320,244 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 0 shares, with a net sale of 320,244 shares. During the past 18 months, 645,402 shares of Edgewise Therapeutics Inc (EWTX) were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 274,545 shares.
Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Edgewise Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does AdaptHealth Corp do?
Who are the key executives at AdaptHealth Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of AdaptHealth Corp. Other key executives at AdaptHealth Corp include Chief Revenue Officer Shaw Rietkerk , director & 10 percent owner & other: Director by Deputization James E Flynn , and Chief Technology Officer Albert A. Prast .
AdaptHealth Corp (AHCO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in AdaptHealth Corp (AHCO). Other recent insider transactions involving AdaptHealth Corp (AHCO) include a net sale of 335,443 shares made by Albert A. Prast , a net sale of 10,764 shares made by Williams David Solomon Iii , and a net sale of 350,000 shares made by James E Flynn .
In summary, during the past 3 months, insiders sold 33,509 shares of AdaptHealth Corp (AHCO) in total and bought 0 shares, with a net sale of 33,509 shares. During the past 18 months, 1,046,834 shares of AdaptHealth Corp (AHCO) were sold and 720 shares were bought by its insiders, resulting in a net sale of 1,046,114 shares.
AdaptHealth Corp (AHCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AdaptHealth Corp Insider Transactions
- Download to Excel(.xls)
What does Werewolf Therapeutics Inc do?
Who are the key executives at Werewolf Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .
Werewolf Therapeutics Inc (HOWL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Werewolf Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does The Oncology Institute Inc do?
Who are the key executives at The Oncology Institute Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: *Director by Deputization of The Oncology Institute Inc. Other key executives at The Oncology Institute Inc include 10 percent owner Havencrest Healthcare Partners, L.p. , Chief Financial Officer & other: Principal Financial Officer Mihir Shah , and director & Chief Executive Officer Brad Hively .
The Oncology Institute Inc (TOI) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in The Oncology Institute Inc (TOI). Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net sale of 80,000 shares made by Havencrest Healthcare Partners, L.p. , a net sale of 72,000 shares made by Brad Hively , and a net purchase of 100,000 shares made by Mihir Shah .
In summary, during the past 3 months, insiders sold 0 shares of The Oncology Institute Inc (TOI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 152,000 shares of The Oncology Institute Inc (TOI) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 52,000 shares.
The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.
The Oncology Institute Inc Insider Transactions
- Download to Excel(.xls)
What does CareMax Inc do?
Who are the key executives at CareMax Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: *Director by Deputization of CareMax Inc. Other key executives at CareMax Inc include director & 10 percent owner De La Torre Ralph , EVP and COO Solo Alberto De , and director & President and CEO De Solo Carlos A. .
CareMax Inc (CMAX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc (CMAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc (CMAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CareMax Inc (CMAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CareMax Inc Insider Transactions
- Download to Excel(.xls)
What does Terns Pharmaceuticals Inc do?
Who are the key executives at Terns Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Terns Pharmaceuticals Inc. Other key executives at Terns Pharmaceuticals Inc include Chief Financial Officer Mark J. Vignola , director & 10 percent owner Carl L Gordon , and director & 10 percent owner Orbimed Advisors Llc .
Terns Pharmaceuticals Inc (TERN) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 5,531 shares made by Mark J. Vignola , a net sale of 47,000 shares made by Jill M. Quigley , and a net purchase of 15,531 shares made by Seokho Bryan Yoon .
In summary, during the past 3 months, insiders sold 27,235 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 476,190 shares, with a net purchase of 448,955 shares. During the past 18 months, 589,991 shares of Terns Pharmaceuticals Inc (TERN) were sold and 509,363 shares were bought by its insiders, resulting in a net sale of 80,628 shares.
Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Terns Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Ignyte Acquisition Corp do?
Who are the key executives at Ignyte Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .
Ignyte Acquisition Corp (IGNYU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ignyte Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does PepGen Inc do?
Who are the key executives at PepGen Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible Member of 10% Group of PepGen Inc. Other key executives at PepGen Inc include See Remarks Michelle L Mellion , See Remarks Niels Svenstrup , and director & 10 percent owner Ra Capital Healthcare Fund Lp .
PepGen Inc (PEPG) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 50,000 shares made by Michelle L Mellion , a net sale of 29,556 shares made by James G Mcarthur , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of PepGen Inc (PEPG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 91,250 shares of PepGen Inc (PEPG) were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,468,037 shares.
PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.
PepGen Inc Insider Transactions
- Download to Excel(.xls)
What does Xilio Therapeutics Inc do?
Who are the key executives at Xilio Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible Member of 10% Group of Xilio Therapeutics Inc. Other key executives at Xilio Therapeutics Inc include 10 percent owner Atlas Venture Fund Xi, L.p. , Chief Medical Officer Katarina Luptakova , and Chief Operating Officer Christopher James Frankenfield .
Xilio Therapeutics Inc (XLO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .
In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.
Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xilio Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Singular Genomics Systems Inc do?
Who are the key executives at Singular Genomics Systems Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible Member of 10% Group of Singular Genomics Systems Inc. Other key executives at Singular Genomics Systems Inc include director & 10 percent owner & Chief Executive Officer Andrew Spaventa , Chief Scientific Officer Eli N. Glezer , and Chief Operating Officer Jyotsna Ghai .
Singular Genomics Systems Inc (OMIC) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Singular Genomics Systems Inc (OMIC). Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 370,000 shares made by Eli N. Glezer , a net purchase of 118,293 shares made by Andrew Spaventa , and a net sale of 631,648 shares made by Kim P. Kamdar .
In summary, during the past 3 months, insiders sold 175 shares of Singular Genomics Systems Inc (OMIC) in total and bought 122,416 shares, with a net purchase of 122,241 shares. During the past 18 months, 21,230 shares of Singular Genomics Systems Inc (OMIC) were sold and 138,698 shares were bought by its insiders, resulting in a net purchase of 117,468 shares.
Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Singular Genomics Systems Inc Insider Transactions
- Download to Excel(.xls)
What does Nuvalent Inc do?
Who are the key executives at Nuvalent Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by Deputization of Nuvalent Inc. Other key executives at Nuvalent Inc include See Remarks Darlene Noci , Chief Financial Officer Alexandra Balcom , and director & 10 percent owner & other: Director by Deputization James E Flynn .
Nuvalent Inc (NUVL) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Nuvalent Inc (NUVL). Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 128,678 shares made by Deborah Ann Miller , a net sale of 536,000 shares made by Matthew Shair , and a net sale of 143,000 shares made by Darlene Noci .
In summary, during the past 3 months, insiders sold 2,149,629 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 2,149,629 shares. During the past 18 months, 3,928,200 shares of Nuvalent Inc (NUVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,928,200 shares.
Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuvalent Inc Insider Transactions
- Download to Excel(.xls)
What does DA32 Life Science Tech Acquisition Corp do?
Who are the key executives at DA32 Life Science Tech Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: Director by deputization of DA32 Life Science Tech Acquisition Corp. Other key executives at DA32 Life Science Tech Acquisition Corp include director & 10 percent owner Keith Crandell , 10 percent owner & other: Director by Deputization Section 32 Fund 3, Lp , and 10 percent owner Arch Venture Fund Xi, L.p. .
DA32 Life Science Tech Acquisition Corp (DALS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DA32 Life Science Tech Acquisition Corp (DALS)'s detailed insider trading history can be found in Insider Trading Tracker table.
DA32 Life Science Tech Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Ignyte Acquisition Corp do?
Who are the key executives at Ignyte Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include 10 percent owner Ignyte Sponsor Llc , director & 10 percent owner & Co-Chief Executive Officer David I. Rosenberg , and director & 10 percent owner & Co-Chief Executive Officer David J. Strupp .
Ignyte Acquisition Corp (IGNY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ignyte Acquisition Corp (IGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ignyte Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Mallinckrodt PLC do?
Who are the key executives at Mallinckrodt PLC?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: *Possible member of 10% group of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include 10 percent owner Alta Fundamental Advisers Llc , EVP & Head of Corp Development Jason Daniel Goodson , and director & President and CEO Sigurdur O Olafsson .
Mallinckrodt PLC (MCKPF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MCKPF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MCKPF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Mallinckrodt PLC (MCKPF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mallinckrodt PLC Insider Transactions
- Download to Excel(.xls)
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: * Director by deputization of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: Director by deputization James E Flynn .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Peak Bio Inc do?
Who are the key executives at Peak Bio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Peak Bio Inc. Other key executives at Peak Bio Inc include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .
Peak Bio Inc (PKBO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Peak Bio Inc (PKBO). Other recent insider transactions involving Peak Bio Inc (PKBO) include a net purchase of 190,250 shares made by Hoyoung Huh ,
In summary, during the past 3 months, insiders sold 0 shares of Peak Bio Inc (PKBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Peak Bio Inc (PKBO) were sold and 190,250 shares were bought by its insiders, resulting in a net purchase of 190,250 shares.
Peak Bio Inc (PKBO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Peak Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. , and 10 percent owner & other: Possible Member of 10% Group Deerfield Partners, L.p. .
Frazier Lifesciences Acquisition Corp (FLAC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does ARS Pharmaceuticals Inc do?
Who are the key executives at ARS Pharmaceuticals Inc?
Deerfield Management Company, L.p. (series C) is the director & 10 percent owner & other: * Director by deputization of ARS Pharmaceuticals Inc. Other key executives at ARS Pharmaceuticals Inc include Chief Financial Officer Kathleen D. Scott , 10 percent owner & Chief Medical Officer Sarina Tanimoto , and director & 10 percent owner & President and CEO Richard E Lowenthal .
ARS Pharmaceuticals Inc (SPRY) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 1,603,260 shares made by Sarina Tanimoto , a net sale of 1,603,260 shares made by Richard E Lowenthal , and a net sale of 543,896 shares made by Laura Shawver .
In summary, during the past 3 months, insiders sold 3,229,754 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 0 shares, with a net sale of 3,229,754 shares. During the past 18 months, 5,780,170 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,937,557 shares were bought by its insiders, resulting in a net purchase of 3,157,387 shares.
ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARS Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. , and 10 percent owner & other: Possible Member of 10% Group Deerfield Partners, L.p. .
Frazier Lifesciences Acquisition Corp (FLACU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLACU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Korro Bio Inc do?
Who are the key executives at Korro Bio Inc?
Deerfield Management Company, L.p. (series C) is the 10 percent owner & other: Possible Member of 10% Group of Korro Bio Inc. Other key executives at Korro Bio Inc include Chief Financial Officer Vineet Agarwal , 10 percent owner Scott D Sandell , and 10 percent owner New Enterprise Associates 17, L.p. .
Korro Bio Inc (KRRO) Insider Trades Summary
Over the past 18 months, Deerfield Management Company, L.p. (series C) made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 2,124 shares made by David L. Lucchino , a net purchase of 17,857 shares made by Forest Baskett , and a net purchase of 17,857 shares made by Paul Edward Walker .
In summary, during the past 3 months, insiders sold 10,216 shares of Korro Bio Inc (KRRO) in total and bought 0 shares, with a net sale of 10,216 shares. During the past 18 months, 12,340 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 166,230 shares.
Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Korro Bio Inc Insider Transactions
- Download to Excel(.xls)
Deerfield Management Company, L.p. (series C) Mailing Address
Above is the net worth, insider trading, and ownership report for Deerfield Management Company, L.p. (series C). You might contact Deerfield Management Company, L.p. (series C) via mailing address: 345 Park Avenue South, 12th Floor, New York Ny 10010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
